GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$0.0135
+0 (+0%)
At Close: Apr 05, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0135 $0.0135 Friday, 5th Apr 2024 ATHX stock ended at $0.0135. During the day the stock fluctuated 0% from a day low at $0.0135 to a day high of $0.0135.
90 days $0.0116 $0.0212
52 weeks $0.0116 $1.14

Historical Athersys prices

Date Open High Low Close Volume
2023-12-15 $0.0230 $0.0260 $0.0200 $0.0250 543 912
2023-12-14 $0.0228 $0.0269 $0.0228 $0.0259 625 188
2023-12-13 $0.0230 $0.0266 $0.0230 $0.0235 534 509
2023-12-12 $0.0230 $0.0268 $0.0211 $0.0230 279 631
2023-12-11 $0.0278 $0.0278 $0.0240 $0.0241 204 668
2023-12-08 $0.0254 $0.0278 $0.0230 $0.0241 256 178
2023-12-07 $0.0211 $0.0280 $0.0211 $0.0280 767 473
2023-12-06 $0.0263 $0.0293 $0.0200 $0.0255 2 811 233
2023-12-05 $0.0183 $0.0270 $0.0167 $0.0235 1 006 247
2023-12-04 $0.0155 $0.0187 $0.0150 $0.0178 290 465
2023-12-01 $0.0179 $0.0187 $0.0150 $0.0160 1 861 381
2023-11-30 $0.0170 $0.0185 $0.0151 $0.0174 1 300 919
2023-11-29 $0.0167 $0.0198 $0.0166 $0.0175 498 201
2023-11-28 $0.0181 $0.0181 $0.0165 $0.0175 990 487
2023-11-27 $0.0170 $0.0239 $0.0170 $0.0180 2 115 454
2023-11-24 $0.0200 $0.0200 $0.0180 $0.0200 281 633
2023-11-22 $0.0164 $0.0210 $0.0164 $0.0200 1 487 611
2023-11-21 $0.0175 $0.0198 $0.0160 $0.0175 741 305
2023-11-20 $0.0175 $0.0199 $0.0165 $0.0175 1 446 327
2023-11-17 $0.0200 $0.0240 $0.0173 $0.0180 1 135 773
2023-11-16 $0.0195 $0.0240 $0.0170 $0.0172 2 163 281
2023-11-15 $0.0188 $0.0263 $0.0160 $0.0195 3 926 852
2023-11-14 $0.0225 $0.0275 $0.0187 $0.0199 3 590 001
2023-11-13 $0.0260 $0.0328 $0.0199 $0.0219 1 728 561
2023-11-10 $0.0227 $0.0295 $0.0227 $0.0275 1 090 264
Click to get the best stock tips daily for free!

About Athersys

Athersys Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study f... ATHX Profile

Golden Star

Ticker Date Change Price
FTSL Apr 16 0.304% $46.08
FCN Apr 16 0.0096% $207.62
ELV Apr 16 3.59% $506.97
ITCI Apr 05 5.20% $68.44
AKR Apr 05 1.33% $16.53
SARK Mar 28 16.44% $26.88
ARCC Mar 25 1.49% $20.12
STT Mar 19 0.578% $72.62
BK Mar 19 0.0181% $55.24
LNC Mar 18 0.221% $27.17
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT